The Column-06-04-2019

Click the title above to open The Column June 2019 Europe & Asia issue, Volume 15, Number 6, in an interactive PDF format.

Click the title above to open The Column June 2019 North American issue, Volume 15, Number 6, in an interactive PDF format.

The Column spoke to Robert Shaw, Steph Turnbull, and Sophie Bailes from AstraZeneca about their work in quality by design (QbD) in the pharmaceutical industry.

Calling all innovators (or anyone seeking to justify a new instrument purchase)!

A newly developed HILIC stationary phase containing modified diol groups on a polymer-based particle has offered renewed hope of an alternative to IP-reversed-phase LC.

This is the third in a series of articles exploring current topics in separation science that will be addressed at the HPLC 2019 conference in Milan, Italy, from 16–20 June.

This is the fourth in a series of articles exploring current topics in separation science that will be addressed at the HPLC 2019 conference in Milan, Italy, from 16–20 June.

If given the need to determine drug A or its metabolite in blood, 99% of the time I would choose to start with liquid chromatography–mass spectrometry (LC–MS).

One of the major problems with plastics is recycling. Only a few materials can be recycled and the acceptance of recyclates is sometimes low. GPC/SEC can be applied to investigate the quality of materials containing recycled portions.